statistical software v9.2 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
statistical software v9.2
Statistical Software V9.2, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+software+v9%2E2/sas+version+9+4/pmc11970227__JGS___73___1049___s001-3535-19-26
Average 90 stars, based on 1 article reviews
Statistical Software V9.2, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+software+v9%2E2/sas+version+9+4/pmc11970227__JGS___73___1049___s001-3535-19-26
Average 90 stars, based on 1 article reviews
statistical software v9.2 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: A teachable moment communication process for smoking cessation talk: description of a group randomized clinician-focused intervention Article Snippet: Upon completion of data collection, coding and survey data will be merged and analyzed using Article Title: Development and Validation of a Salt Food Frequency Questionnaire (FFQ-Na) and a Discretionary Salt Questionnaire (DSQ) for the Evaluation of Salt Intake among French-Canadian Population Article Snippet: Article Title: Understanding Waterfall Plots Article Snippet: All analyses used two-sided confidence intervals and Article Title: Adherence to Desvenlafaxine Versus Usual Care and Its Impact on Health Outcomes: A Comparative Real-world Clinical Study. Article Snippet: Background and Objective Low adherence to treatment is associated with poorer clinical outcome and greater healthcare resources utilization (HRU).. Limited data are available on the extent of adherence to each individual antidepressant.. The goal of this study was to compare the adherence rate to desvenlafaxine versus usual care with selective serotonin reuptake inhibitors (SSRI) and/or other serotonin–norepinephrine reuptake inhibitors (SNRI), in subjects with major depressive disorder (MDD). Article Title: Clinical presentation and treatment of tick paralysis in dogs and cats in Sydney (2001-2010). Article Snippet: Results Doses of TAS in excess of 2 mL/animal, 0.30 mL/kg and 1.25 mL/tick in dogs, and 2 mL/animal, 0.45 mL/kg and 0.38 mL/tick in cats did not significantly alter the time to recovery.. In dogs, a longer time to recovery was associated with cases in winter than in other seasons (P = 0.0099) and with more severe gait scores (P = 0.0002).. There was a trend of longer recovery times in patients with higher respiratory scores (P = 0.0561). Article Title: Effect of vitamin D, omega‐3 supplementation, or a home exercise program on muscle mass and sarcopenia: DO ‐ HEALTH trial Article Snippet: Technical Details All analyses will be performed centrally by the data management team at the DO-HEALTH coordinating center using Article Title: Gene-diet interactions with polymorphisms of the MGLL gene on plasma low-density lipoprotein cholesterol and size following an omega-3 polyunsaturated fatty acid supplementation: a clinical trial Article Snippet: Statistical analyses were performed with |